Liver fibrosis is a grave disease with significant mortality, previously it was believed that only transplantation offers survival chance. However, it has been shown that appropriately adapted therapy, depending on the disease progression, can have a positive impact on the prognosis variability. Stabilization of the disease course depends on adequate prevention of fibrosis complications and the earliest possible initiation of therapeutic measures. In certain situations, fibrosis (even within the range of fibrosis) can regress following targeted treatment.
Cirrhosis of the liver: Pathophysiological mechanisms, structural alterations, and systemic complications
Cirrhosis represents a progressive, irreversible hepatic injury marked by excessive fibrotic tissue deposition and the distortion of the liver’s native structural framework. This pathological remodeling gives rise to irregular, dysfunctional regenerative nodules that supplant healthy parenchyma. The cumulative effect of these alterations is the gradual impairment of the liver’s essential roles—including detoxification, protein synthesis, and the metabolism of lipids and carbohydrates—as well as disruption of portal venous circulation. Left untreated, this culminates in the onset of portal hypertension, hepatic failure, and a cascade of multisystem complications, such as ascites, hepatic encephalopathy, and esophageal variceal hemorrhage.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.